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Diagnosis, Pathophysiology, and Clinical Treatment of a Patient with a Pheochromocytoma
Tricia L. Hale, RN, BSN, CCRN
Otterbein University, Westerville, Ohio
Introduction
Hypertension is an extremely common diagnosis today. This condition can be caused by a multitude
of factors, and can inversely cause numerous unfavorable processes in the body. One rare but
significant source of hypertension is a tumor known as a pheochromocytoma, or PCC.
This usually benign tumor is most often located on an adrenal gland, and can have a grave impact on
the cardiovascular system. The tumor intermittently secretes an excess of the catecholamine
norepinephrine, and if large enough, also secretes epinephrine [9]. These episodic bursts can cause
extreme hypertension and tachycardia, leading to, at times fatal results. By understanding the
pathophysiology and clinical presentation of a pheochromocytoma, this tumor can be considered as part
of the early differential diagnoses by the advanced practice nurse. If a detailed history is obtained, the
PCC patient can be treated appropriately and a potentially tragic outcome may be avoided. Surgical
intervention is the most successful treatment modality, if the patient has been deemed a good candidate
[3]. Careful monitoring must be performed pre-, during, and after surgery, noting any changes in vital
signs or mental status. Pertinent patient education must be provided regarding significant symptoms,
lifestyle modifications and when to seek immediate medical attention.

Diagnosis

A diagnosis of PCC is made base on increased serum and urine
catecholamine and catecholamine metabolite levels. Plasma free
metenephrine measuring, done by immunoassay, has been declared
more sensitive and accurate than measuring urine catecholamine
levels. Positive levels are considered those over 90 ng/L and 125
nmol/day, respectively [6]. Unfortunately, many false-positive test
results occur related to the low number of patients inflicted with a
tumor of this sort. Elevated results also do not distinguish between
the presence of a pheochromocytoma or a paraganglioma. Hence,
once critical levels are identified, radiological studies, such as cat
scan and magnetic resonance imaging, are then performed to
confirm location and size [6].

Treatment
Once diagnosis of a pheochromocytoma is made, options
for treatment can then be discussed. Care is aimed at
managing catecholamine excess and surges, in order to
prevent hypertensive emergency and damaging
cardiovascular effects. Alpha- and beta-adrenergic blockers
are commonly prescribed. Titration of these vasoconstrictors
is often performed on an inpatient unit for tighter control.
Ultimately, if the patient is a candidate, surgical removal of
the pheochromocytoma is the best treatment option. Surgery
can be performed through a laparoscopic approach or by
open incision adrenalectomy. Risk factors are reviewed to
determine the most appropriate procedure. These include
tumor size, patient age, body mass index, and known
anesthesia complications [2]. Vital signs are closely
monitored and controlled, before, during and after the
procedure [3]. Surgery alone is often a cure, although
chemotherapy may accompany the post-surgical regimen at
times.

Pathophysiology, Signs & Symptoms
Implications for Nursing Care
Pheochromocytomas are tumors of the chromaffin cells, most commonly positioned on the adrenal
medulla [8], although sometimes occur throughout the abdomen and thoracic regions, then known as
paragangliomas [5]. Studies have indicated the majority of pheochromocytomas are idiopathic in nature,
with one-fourth of diagnoses containing a genetic component. Both are usually diagnosed between the
ages of thirty-five and fifty [5]. It is estimated that a PCC is present in four to five percent of the
hypertensive population. They seem to occur equally between men and women [8]. They are challenging
to diagnose, as they often appear dormant. When active, excessive catecholamine release causes a
variety of symptoms, with hypertension as the most prominent. This hypertension occurs related to an
increase in peripheral vascular resistance. Stressors to the body, such as exercise, caffeine intake, and
surgery often prompt the catecholamine surge. Foods high in tyrosine, such as yogurt, wine and beer, can
also spark their catecholamine release [9]. Effects of this hypertension, such as cardiomyopathy and
infarction have been seen [1]. Palpitations, anxiety, and heat intolerance can occur. Fluctuation in blood
levels of norepinephrine and epinephrine also lead to headaches and a potential decrease in cerebral
blood flow [9]. One severe case has linked a PCC with a dissecting aneurysm of the vertebral artery [1].
Metabolic increases lead to diaphoresis and otherwise unexplained weight loss. Decreased insulin release
can lead to hyperglycemia [9]. Because of the intermittent presentation of symptoms, As high as twentyone percent of pheochromocytomas are without symptoms, which can be related to the patient’s
tolerance for high levels of catecholamines [8].

Resected pheochromocytoma [7]

Although difficult to assess accurately, malignancy is
suspected in up to ten percent of pheochromocytoma cases.
Without metatastasis, survival rate five years post-diagnosis is
as high as eighty-nine percent. This percentage decreases
drastically as metastasis is involved. Presently studies exist that
are aimed at identifying genetic components and mutations,
although on a large scale, these studies remain a challenge
because the tumor is so rare [8].

Radiologic image of a pheochromocytoma [10]

The informed nurse can be of great importance when
diagnosing the cause of hypertension. By obtaining a detailed
history of both chronic and intermittent symptoms, a pattern
can be established. This pattern is vital when considering a
diagnosis of a pheochromocytoma. Once diagnosed, the nurse
must educate the patient regarding symptoms, emphasizing the
importance of early recognition and when to seek immediate
care . Stress reduction and lifestyle modification are important
treatment modalities. Nurses need to teach their patients
regarding the effect of weight management, diet and exercise,
and non-smoking on healthier outcomes. Evaluating vital signs,
medication effectiveness, reporting important findings to the
physician, monitoring glucose levels, and assisting with pain
control are all important nursing responsibilities, both prior to
and following surgery.

Conclusion
Although rare, a pheochromocytoma can lead to devastating,
even fatal outcomes. Excessive epinepherine and
norepinepherine surges often cause dangerous hypertension
and cardiac decline. Understanding the pathophysiology
involved will enable the advance practice nurse to consider this
tumor as as part of the differential diagnoses. She can recognize
symptoms, aid in diagnosing early, and monitor potentially lifethreatening conditions closely. Treatment includes lab data
collection, anti-hypertensive medication evaluation, monitoring
of vital signs, and pre- and post-surgical care. Patient education
regarding pheochromocytoma is key to patient success.
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